BACKGROUND
Preventing tuberculosis (TB) infection among high-risk groups through tuberculin skin testing (TST) and therapy for latent TB infection (LTBI) is assuming increased importance as the number of active TB cases declines in the United States. 1, 2 One TST program was implemented in 1995 at the prenatal clinics of the University of Miami/Jackson Memorial Hospital (JMH) in Miami, FL, where approximately 2.4% of the prenatal population has human immunodeficiency virus (HIV) infection and 60% is foreign-born. About 6000 women deliver there annually. Two years after JMH started doing TSTs for women seeking prenatal care, we conducted a retrospective medical record review to assess the implementation among HIV-infected women. Our goals were to assess the frequency with which TSTs were placed and read, how results were recorded, the TST results, and the numbers who began therapy for LTBI. We also assessed factors predictive of having a TST done, and having a positive TST.
DEFINITIONS
LTBI is defined as a positive TST, a negative chest X-ray, and no evidence of active TB disease, such as a positive sputum culture for Mycobacterium tuberculosis or clinical signs of TB such as weight loss, night sweats, and hemoptysis. 2, 3 In HIV-infected persons, a TST is considered positive when the induration measures 5 mm or more. 2, 3 When the study was done, recommended therapy for LTBI was 9 months of isoniazid for HIV-infected persons, 4 but additional, shorter regimens with rifampin and PZA now exist. 2, 3 Completing therapy for LTBI during pregnancy is recommended for HIV-infected women. 2, 3 At the time the study was done, simultaneous anergy testing was recommended for HIV-infected persons undergoing TST. 5, 6 At JMH, a person was considered anergic if the TST and antigen panels (candida and mumps) were all negative.
MATERIALS AND METHODS
We evaluated the TSTs done as part of prenatal care during the 2-year period of 1995 and 1996. We used log books in the Perinatal Immunology (PRIM) Clinic, a JMH clinic which serves HIV-infected women, to identify such women seeking prenatal care. The PRIM clinic sees prenatal patients who already know their HIV status and those whose HIV diagnosis is discovered
OBJECTIVE:
Approximately 6000 women deliver annually at Jackson Memorial Hospital in Miami, where 2.4% of women has human immunodeficiency virus ( HIV ) and 60% is foreign -born. We conducted a retrospective review of prenatal records among HIV -infected women to evaluate tuberculin skin testing ( TST ) .
STUDY DESIGN:
We determined how many women had TSTs placed and read, and the TST results.
RESULTS:
We identified 207 HIV -infected women, 87% of such women delivering in 1995 to 1996. Most did not know their HIV status before seeking prenatal care ( 109, 54% ) and most ( 176, 85% ) had TSTs done. Of the women, 45 had positive TSTs, 96 had negative TSTs, and 35 were anergic. Most results were not recorded using millimeters of induration. Two women ( 1% ) had active tuberculosis ( TB ) disease.
CONCLUSION:
Overall, 21% of all HIV -infected women had positive TSTs and 1% had active TB disease. Focused TB skin testing should be part of routine prenatal care in clinics serving populations at high -risk for TB, such as those with HIV infection and the foreign -born. Original Article
during routine prenatal testing. Pregnant, HIV-infected women who need therapy for LTBI or active TB disease are treated in the PRIM clinic. Medical records from prenatal visits and labor and deliveries were abstracted by a registered nurse (P. B.) who recorded demographics (age, race/ethnicity), timing of prenatal visits, pregnancy history, testing information for TB and HIV, and risk factors for TB (exposure to TB, a history of drug use), and starting TB therapy for active disease or LTBI. We also assessed whether TST results were recorded in millimeters of induration, as recommended by CDC, 2 or only as positive or negative. The study protocol was approved by Institutional Review Boards at CDC and the University of Miami.
STATISTICAL ANALYSIS
Descriptive statistics were used to characterize the pregnant women who received TSTs, had positive test results, and began on treatment for LTBI. Among the foreign-born women, we also assessed whether there was an association between country of origin (Haiti versus all others), length of US residence, and having a skin test placed and read and starting therapy for LTBI. A length of US residence less than 5 years was chosen because more than half of all US TB cases reported among the foreign-born develops in that time period. 7 We also performed univariate analysis and logistic regression to assess factors predictive of having TSTs placed and read while pregnant and of having a positive TST. Dependent variables evaluated in the stepwise logistic regression models included age (adolescent versus older), birth place (foreign versus USA), timing of prenatal care (first trimester versus all other), exposure to TB, and a history of illicit drug use, whether HIV status was unknown at the first prenatal visit and if an AIDS-defining condition existed at the first prenatal visit. Epi Info, version 6, was used for data entry, descriptive statistics, and univariate analysis; 8 SAS version 6.12 was used for multivariate logistic regression. 9 Results are reported as odds ratio (OR) with 95% confidence interval (CI).
RESULTS

Characteristics of HIV-Infected Women
We identified 207 HIV-infected women who delivered at Jackson Memorial in 1995 to 1996, representing 87% of the 239 HIV-infected women who delivered in those years. Of the 31 women not included in this study, 9 had no prenatal care and 22 had prenatal care at a site besides JMH.
Among the 207 women in the study, most women were US-born (112, 54%) and did not know their HIV status (111, 54%) before beginning prenatal care. The women's median age was 26 years (range 15 to 45 years) and the median number of pregnancies was three (range 1 to 13). Of the 95 foreign-born women, all had immigrated from Caribbean and Latin American countries, most frequently Haiti (61, 64%), and had been US residents a median of 8 years (range 1 to 25 years).
Most women and had TSTs placed and read (176, 84%), of whom 45 had positive TSTs, 96 had negative TSTs, and 35 were considered anergic. The TST results were recorded only as positive or negative for 97% (170) of the women, not in millimeters of induration. Two other women (1%) who underwent screening as part of prenatal care had positive cultures for M. tuberculosis and were treated for active TB disease during pregnancy.
Among the 95 foreign-born women, there was no association between Haitian birth and having a TST placed and read (OR 0.89; 95% CI 0.08 to 6.62) or between US residence of 5 years or less and having a TST placed and read (OR 1.42; 95% CI 0.07 to 86.00). Nor was there any association between Haitian birth and having a positive TST (OR 0.86; 95% CI 0.31 to 2.59) or between length of US residence and beginning LTBI therapy (OR 1.19; 95% CI 0.41 to 3.43). Because neither a specific foreign country or length of US residence was significant, they were not included in the logistic regression models.
Results of Models
Having a tuberculin skin test placed and read was associated with foreign birth and an unknown HIV status at the first prenatal visit in the univariate analysis. (Table 1 ). Only foreign birth remained significant in the multivariate model. Having a positive TST was Table 2) .
Starting Therapy for LTBI Eighty women were eligible for LTBI, based on a positive TST (n=45) or anergic status (n=35), and 45 (20 anergic and 25 with positive TSTs) began therapy during pregnancy. One of the 45 women who began therapy developed isoniazid-associated hepatitis and discontinued therapy. We were unable to collect information about how many women completed therapy for active disease or LTBI or how many women who deferred therapy during pregnancy began it after delivery.
DISCUSSION
This study, assessing the inclusion of TSTs in routine prenatal care for HIV-infected women in Miami, found the practice to be useful in a hospital were 60% of pregnant women are foreign-born and 2% of pregnant women are HIV-infected, but do not know their HIV status before seeking prenatal care. In this study of pregnant, HIV-infected women, 1% was diagnosed with active TB disease and 26% had positive TSTs, a figure higher than the 6% to 15% reported in four other studies. 10 -13 Among women tested, foreign-born women were almost 30 times more likely to have a positive TST than US-born women. These findings suggest that prenatal clinics serving HIV-infected women or those who are foreign-born are logical places to conduct focused TST screening. It also has practical implications for both TB programs in public health departments and obstetrician-gynecologists staffing prenatal clinics.
As the rate of active TB disease in the United States has decreased, identification and treatment of persons with LTBI have assumed a high priority in efforts to eliminate the disease in the US.
2 TB programs are now making efforts to do TSTs in clinics and other medical facilities serving groups at high risk of acquiring TB infection or disease including persons with HIV infection, drug users, prisoners, and the foreign-born. 1 -3 Focused screening programs that can reach the foreign-born are especially important because percentages of US TB cases attributed to foreign-born persons have increased for more than a decade, 14 and the numbers of US immigrants from countries with high TB prevalence also have increased during the same time. 15 If TB programs are to expect cooperation with TST screening from facilities like the prenatal clinics at JMH, effective TB training must be developed to permit obstetricians and gynecologists to effectively test for TB and to treat LTBI. Implementing routine TST screening in clinics with a primary emphasis other than TB is problematic. The issues in starting such TST programs include identifying the segments of populations at risk for TB in medical settings, properly administering and reading the TSTs, arranging appropriate therapy for LTBI or active TB disease, and monitoring women for side effects, such as hepatitis. 2, 3 This study and others suggest that implementing TST screening in prenatal clinics may be difficult. In this study, the vast majority of women did not have TST results properly recorded. In other studies, investigators have found that 25% of Hispanic prenatal patients 10, 13 had positive TSTs, but did not collect information about risk factors such as foreign birth. Additional issues that must be addressed include whether a woman who starts TB therapy while pregnant completes it or begins it after delivery. The results of the study indicate that many women with positive TSTs did not begin therapy, and a limitation of this medical record study is we are unable to determine whether patients did not accept treatment or providers did not offer it. In this study, we were unable to assess completion of therapy by women who begin it in pregnancy or to determine how many women began therapy for LTBI after delivery. Nor were we able to assess factors associated with the medical decisions to start or defer therapy for LTBI during pregnancy.
In summary, this study found that the JMH prenatal clinics are logical sites to implement focused tuberculin screening programs, but that knowledge of TB screening and therapy must be included if such TST programs are to operate successfully. The JMH policy of serial HIV and TST testing in the prenatal clinic is productive and reaches women who might otherwise have gone undetected. It is also important to note that many American-born women in this study did not know their HIV status before starting prenatal care; it is important that obstetric health care providers offer HIV testing to all pregnant 
